Pharmacology of naphthoquinones, with special reference to the antimalarial activity of Lapinone (WR 26, 041).
D062365:Aminobenzoates / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D004247:DNA / Q000037:antagonists & inhibitors; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D004912:Erythrocytes / Q000502:physiology; D005492:Folic Acid / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D007022:Hypotension / Q000139:chemically induced; D051379:Mice; D009285:Naphthoquinones / Q000494:pharmacology* / Q000633:toxicity; D010961:Plasmodium / Q000187:drug effects*; D012313:RNA / Q000037:antagonists & inhibitors; D051381:Rats
D062365:Aminobenzoates; D000962:Antimalarials; D009285:Naphthoquinones; D012313:RNA; D004247:DNA; D005492:Folic Acid; D004837:Epinephrine